Escalon Medical Revenue Growth Rates (ESMC), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Escalon Medical Corp   (ESMC)
 

ESMC's Revenue Growth by Quarter and Year

Escalon Medical 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/ESMC/growth
https://api.csimarket.com/api/v1/companies/ESMC/fundamentals
https://api.csimarket.com/api/v1/companies/ESMC/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Financial API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
ESMC Revenue (in millions $) FY 2024 FY 2023 FY 2022 FY 2021
4th Quarter June 3.86
3rd Quarter March 2.61
2nd Quarter December 3.59
1st Quarter September 2.68
FY 12.74

ESMCs Annual Revenue
Escalon Medical 's Revenue in the fiscal year 2026 $ 12.74 millions
Escalon Medical 's Revenue in the fiscal year 2025 $ 12.05 millions
Escalon Medical 's Revenue in the fiscal year 2024 $ 11.98 millions
Escalon Medical 's Revenue in the fiscal year 2023 $ 12.18 millions
Escalon Medical 's Revenue in the fiscal year 2022 $ 10.70 millions




ESMC Revenue fourth quarter 2024 Y/Y Growth Comment
Escalon Medical Corp achieved in the fourth quarter 2024, above Company average Revenue rise of 50.23% year on year, to $ 3.86 millions.

Looking into fourth quarter 2024 results within Medical Equipment & Supplies industry 16 other companies have achieved higher Revenue growth. While Escalon Medical Corp ' s Revenue jump of 50.23% ranks overall at the positon no. 402 in the fourth quarter 2024.


ESMC Revenue ( Y/Y Growth %) 2024
 FY 2023 FY 2022 FY 2021
4th Quarter June 50.23 %
3rd Quarter March -24.78 %
2nd Quarter December 11.49 %
1st Quarter September -3.6 %
FY   5.82 %

Financial Statements
Escalon Medical 's fourth quarter 2024 Revenue $ 3.86 millions ESMC's Income Statement
Escalon Medical 's fourth quarter 2023 Revenue $ 2.57 millions Quarterly ESMC's Income Statement


ESMC Revenue (Quarter on Quarter Growth %)

 2024
 FY 2023 FY 2022 FY 2021
4th Quarter June 47.93 %
3rd Quarter March -27.3 %
2nd Quarter December 33.96 %
1st Quarter September 4.28 %
FY (Year on Year)   5.82 %


Back to ESMC Growth rate Comparisons >> Back to ESMC Growth rate Comparisons >>


Revenue fourth quarter 2024 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #17
Healthcare Sector #112
Overall #402

Revenue Y/Y Growth Statistics
High Average Low
50.22 % -2.25 % -76.18 %
(Sep 30 2023)   (Sep 30 2016)
Revenue fourth quarter 2024 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #17
Healthcare Sector #112
Overall #402
Revenue Y/Y Growth Statistics
High Average Low
50.22 % -2.25 % -76.18 %
(Sep 30 2023)   (Sep 30 2016)

Revenue by Quarter for the Fiscal Years 2021, 2022, 2023, 2024

Escalon Medical 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
160.9 % 3.58 % -79.32 %
(Dec 31 2011)  


ESMC's IV. Quarter Q/Q Revenue Comment
Escalon Medical Corp achieved in the IV. Quarter 2024 above company average sequential Revenue jump of 47.93%, to $ 3.86 millions, from $2.61 millions in the third quarter.
ESMC is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.

Within Medical Equipment & Supplies industry 5 other companies have achieved higher Revenue quarter on quarter growth. While Escalon Medical 's Revenue growth quarter on quarter, overall rank is 296.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #6
Healthcare Sector #70
Overall #296
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #6
Healthcare Sector #70
Overall #296
Revenue Q/Q Growth Statistics
High Average Low
160.9 % 3.58 % -79.32 %
(Dec 31 2011)  


ESMC's IV. Quarter Q/Q Revenue Comment
Escalon Medical Corp achieved in the IV. Quarter 2024 above company average sequential Revenue jump of 47.93%, to $ 3.86 millions, from $2.61 millions in the third quarter.
ESMC is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.

Within Medical Equipment & Supplies industry 5 other companies have achieved higher Revenue quarter on quarter growth. While Escalon Medical 's Revenue growth quarter on quarter, overall rank is 296.


Escalon Medical 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2026)		 12 Months Ending (Mar 31 2026) 12 Months Ending (Dec 31 2025) 12 Months Ending (Sep 30 2025) 12 Months Ending (Jun 30 2025)
Cumulative Revenue 12 Months Ending $ 12.74
Y / Y Revenue Growth (TTM) 5.73 %
Year on Year Revenue Growth Overall Ranking # 2342
Seqeuential Revenue Change (TTM) 11.28 %
Seq. Revenue Growth (TTM) Overall Ranking # 3019


Cumulative Revenue growth Comment
Escalon Medical saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 5.73% year on year, to $ 13 millions if the fiscal year would have ended in Jun 30 2026.
Escalon Medical 's trailing twelve months Revenue growth was higher than company's average 0.48% and higher than -11.61% growth in Mar 31 2026.

In the Healthcare sector 364 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 720 to 2342.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 138
Healthcare Sector # 365
Overall # 2342

Revenue TTM Y/Y Growth Statistics
High Average Low
17.75 %
 0.48 %
-16.26 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 138
Sector # 413
S&P 500 # 3019
Cumulative Revenue growth Comment
Escalon Medical saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 5.73% year on year, to $ 13 millions if the fiscal year would have ended in Jun 30 2026.
Escalon Medical 's trailing twelve months Revenue growth was higher than company's average 0.48% and higher than -11.61% growth in Mar 31 2026.
The momentum is even more impressive from twelve months ended Mar 31 2026 exhibited at 11.28 % increase from $11.45 millions in the period from Mar 31 2026 to Jun 30 2025.

In the Healthcare sector 364 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 720 to 2342.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 138
Healthcare Sector # 365
Overall # 2342

Revenue TTM Y/Y Growth Statistics
High Average Low
17.75 %
0.48 %
-16.26 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 138
Sector # 413
S&P 500 # 3019




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
ESMC's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue jump for the quarter ending Jun 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2026
Fennec Pharmaceuticals Inc 85.18%$ 85.184 millions
Alamar Biosciences Inc 82.08%$ 82.075 millions
Seastar Medical Holding Corp81.95%$ 81.953 millions
Sera Prognostics Inc 76.47%$ 76.471 millions
Innovative Eyewear Inc 74.46%$ 74.459 millions
Madrigal Pharmaceuticals Inc 71.17%$ 71.169 millions
Tg Therapeutics Inc 70.27%$ 70.272 millions
Tarsus Pharmaceuticals Inc 69.41%$ 69.406 millions
Hyperfine Inc 67.70%$ 67.698 millions
Alnylam Pharmaceuticals Inc 66.86%$ 66.856 millions
Emergent Biosolutions Inc 66.29%$ 66.288 millions
Vivos Therapeutics Inc 65.69%$ 65.691 millions
Iovance Biotherapeutics inc 65.65%$ 65.654 millions
Billiontoone Inc 64.40%$ 64.403 millions
Anteris Technologies Global Corp 63.27%$ 63.269 millions
Nexgel Inc 63.24%$ 63.242 millions
Carlsmed Inc 59.58%$ 59.575 millions
Sonoma Pharmaceuticals Inc 59.55%$ 59.552 millions
Arcutis Biotherapeutics Inc 59.33%$ 59.331 millions
Nephros Inc 58.55%$ 58.551 millions
Kiniksa Pharmaceuticals International Plc55.36%$ 55.360 millions
Bioadaptives Inc 54.95%$ 54.955 millions
Zevra Therapeutics Inc 53.25%$ 53.251 millions
Beyond Air Inc 52.94%$ 52.941 millions
Caredx Inc 52.23%$ 52.226 millions
Bioxcel Therapeutics Inc 51.67%$ 51.667 millions
Glaukos Corp50.63%$ 50.628 millions
Escalon Medical Corp 50.22%$ 50.225 millions
Heartflow Inc 49.80%$ 49.801 millions
Organigram Global Inc 49.43%$ 49.432 millions


About Escalon Medical Revenue Growth Rates (ESMC), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Escalon Medical Corp (CIK 862668).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001628280-26-065683
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Escalon Medical Corp’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.